Rosmantuzumab: A Deep Dive into OMP-131R10 Rosmantuzumab, originally known as OMP-131R10, represents a novel monoclonal immunoglobulin developed to target granulocyte-macrophage colony-stimulating FMS-like tyrosine https://omp-131r10562192.pointblog.net/text-94907994